Learn more about eLife assessments Blood flow to the brain is a sensitive marker of neuronal activity as well as of a number of diseases, including stroke, tumours and neurodegenerative conditions.

Policybazaar for Business has launched AiSHA, an industry-first AI-powered Smart Face Scan and Health Assistant for its ...

In a Liv Hospital study, stem cell therapy improved heart function dramatically using MSCs and EVs, despite a blocked graft.

No one's crossed the finishing line yet, but drug developer Nyrada is leading the Great Biotech Regatta of 2025 with close to ...

Doctors may soon be able to diagnose an elusive form of heart disease within seconds by using an AI model developed at University of Michigan, according to a recent study.

Several ASX healthcare names secured US Food and Drug Administration approval in 2025, opening up the world's largest healthcare market.

New U.S. guidelines emphasize treating peripheral artery disease (PAD) as a critical warning sign for overall cardiovascular ...

The AI model will help “clinicians to accurately identify” coronary microvascular dysfunction (CMVD), which is hard to ...

In 2025, the medtech industry saw another year full of all kinds of deals in the mergers and acquisitions (M&A) arena.

With the sun setting on another ‘issues rich’ year for ASX biotechs, Dr Boreham applies his stethoscope to the soaring ...

Doctors have sounded the alarm after Kim Kardashian revealed she has 'low brain activity.' The news follows a recent scan which detected an aneurysm that could burst at any moment.

Objectives This study assessed whether a previously developed Monte Carlo simulation model can be reused for evaluating various strategies to minimise time-to-treatment in southwest Netherlands for ...